FDA approval of a generic topical tretinoin formulation; regulatory action, not clinical evidence of efficacy or safety.
Reported
Strength0.08%
FormulationGel, topical
Approval date2026-05-14
Loading
Drug or technology
1 development in the corpus
Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
Latest
Everything in the corpus, newest first.
FDA approval of a generic topical tretinoin formulation; regulatory action, not clinical evidence of efficacy or safety.